APIMEDS PHARMACEUTICALS US, INC. Common Stock, Convertible, Conversion Price, Decrease
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Common Stock, Convertible, Conversion Price, Decrease of $2.60 per share for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockConvertibleConversionPriceDecrease · last filed 2025-11-12
- 2025-09-30: Common Stock, Convertible, Conversion Price, Decrease 9 month $2.60.
- 2025-06-30: Common Stock, Convertible, Conversion Price, Decrease 6 month $2.60.
| Period end | Common Stock, Convertible, Conversion Price, Decrease 6 month | Common Stock, Convertible, Conversion Price, Decrease 9 month |
|---|---|---|
| 2025-09-30 | $2.60 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.60 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |